Promising Schizophrenia Drug, Cobenfy, Will Likely Face Access Challenges

The newly approved schizophrenia drug, Cobenfy, offers a novel treatment approach targeting cholinergic receptors. Despite its potential benefits, challenges like high cost and insurance coverage restrictions may limit patient access.